Content uploaded by Takeshi Tsuda
Author content
All content in this area was uploaded by Takeshi Tsuda on Jan 08, 2016
Content may be subject to copyright.
Journal of Heart and
Cardiology
Editorial
Takeshi Tsuda*
Corresponding author: Associate Professor of Pediatrics,
Sidney Kimmel Medical College of Thomas Jefferson, Uni-
versity, and Philadelphia, PA 19107 Tel: (302)651-6677; Fax:
(302)651-6601; E-mail: ttsuda@nemours.org
Received Date: December 29, 2014
Accepted Date: December 30, 2014
Published Date: December 31, 2014
Citation: Tsuda, T. The importance of Cardiovascular Research: What
are we looking for? (2014) J Heart Cardiol 1(1): 1-2.
J Heart Cardiol | Volume 1: Issue 1
www.ommegaonline.com
Editorial
I used to naively and optimistically believe that the ad-
vance in medical science and technology would eventually solve
the majority of clinical problems. In the mid 80s when I was
a medical student in Japan, cancer disorders were perceived as
“progressive and lethal” by both physicians and patients. Treat-
ment strategy was still empiric and far from strategic and com-
prehensive. Without question, they were the biggest challenges
and threats to the entire society at that time. Thanks to marvelous
progress in integrated management with chemotherapy, surgical
intervention, and radiation therapy, etc., the modern medicine
has been able to conquer some types of cancers. Instead, howev-
er, we began to see increased number of heart failure in cancer
survivors secondary to specic cancer chemotherapy[1]. By solv-
ing one existing problem, we simply created another problem:
chemotherapy-induced-cardiomyopathy. Its pathogenesis and
effective treatment are still not fully understood. Although a
potent chemotherapy has signicantly improved survival and,
in part, quality of life, it is not always complication-free. Some
complications are just as bad as the original disease. With new
therapeutic modalities, we started to see a number of unexpected
new pathological conditions never experienced in the past.
Heart failure is a progressive lethal disease that has
signicant morbidity and mortality. Nearly 5.7 million people
suffer from heart failure in the United States alone (2008)[2], and
20% die within rst year after the diagnosis[3]. This is a signif-
icant social impact. According to the textbook of Colucci and
Braunwald (“Heart Disease”, 6th Ed, 2001, McGraw Hill), heart
failure is dened as “the pathological state or clinical syndrome
in which the heart is unable to pump blood commensurate with
the requirements of the metabolizing tissues or can do so only
with an elevated lling pressure.” Although the nal common
physiological outcome is the same, the underlying mechanisms
that cause heart failure are diverse and complex. The underly-
ing mechanisms of heart failure are poorly understood. Heart is
known as the most durable, integral, and indispensible organ to
maintain life. Besides the natural end of life, we have not yet elu-
cidated the underlying mechanisms of heart failure; nonetheless,
there must be strong factors at play that cause this diligent organ
to stop functioning. What are they? Why does myocardial tissue
fail to work properly? The understanding of molecular biology,
cell and matrix biology, and gene regulation is critical in answer-
ing these questions.
Heart failure is indeed a clinical syndrome involving
multiple organ systems. It is not merely a hemodynamic disabil-
ity of the heart as a pumping organ, but also represents loss of
regulation of the complex network communication among multi-
ple organs including heart, lungs, kidneys, liver, brain, gut, skel-
etal muscles, and endocrine organs, as all depend upon essential
supply provided by the heart. The disruption of these cross-talks
can be both the cause and/or result of failing circulation. What
are the methods in communicating with the distant organs? What
are the hormones that the heart can produce other than natri-
uretic peptides? The understanding of an endocrine role of the
heart is limited and needs to be further investigated[4]. Alteration
in immune system and dysregulated inammatory process are
heavily involved in the development of heart failure[5] and vas-
cular diseases[6]. To better understand the heart disease and the
patients with heart disease, it is imperative for all practicing car-
diologists to appreciate the importance of medical research, both
basic and clinical. Research is an unending human endeavor to
tackle unanswered questions we encounter for the patients and
for ourselves.
In the modern era, there are much more to learn than
what we used to learn in the past. As Hippocrates said, “Art is
long, life is short, opportunity eeting, experience treacherous,
judgment difcult”, there is so much to learn and so little to ac-
quire within a limited time. We sometimes lose ourselves in
the midst of the enormity, complexity and diversity of available
medical information. But this is who we are as medical profes-
sionals to be able to serve our patients. Any research experience
in the professional career would likely to help each individual
guide to make a sound judgment in the chaos. Investing your
time and effort in research activity does not pay off immediately,
but would certainly help you build up your future professional
strength when you encounter these problems.
The importance of Cardiovascular Research: What are we looking for?
Copy rights: ©2014 Tsuda, T. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0
International License. 1
Cardiologist, Nemours Cardiac Center, Nemours/Alfred I. duPont Hospital for Children, 1600 Rockland Rd, Wilmington, DE, 19803, Philadel-
phia
Tsuda, T
2
References
1. Hahn, V.S., Lenihan, D.J., Ky, B. Cancer therapy-induced cardio-
toxicity: Basic mechanisms and potential cardioprotective therapies.
(2014) J American Heart Association 3: e000665.
2. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., et al. Heart disease and
stroke statistics--2012 update: A report from the american heart associ-
ation. (2012) Circulation 125(1): 187-197.
3. Stewart, S., MacIntyre, K., Hole, D.J., et al. More “malignant” than
cancer? Five-year survival following a rst admission for heart failure.
(2001) Eur J Heart 3(3): 315-322.
4. Clerico, A., Recchia, F.A., Passino, C., et al. Cardiac endocrine func-
tion is an essential component of the homeostatic regulation network:
Physiological and clinical implications. (2006) Am J Physiol Heart Circ
Physiol 290(1): 17-29.
5. Van Linthout, S., Miteva, K., Tschope, C. Crosstalk between bro-
blasts and inammatory cells. (2014) Cardiovasc Res 102(2): 258-269
6. Schober, A. Chemokines in vascular dysfunction and remodeling.
Arteriosclerosis, thrombosis, and vascular biology. (2008) Arterioscler
Thromb Vasc Biol 28(11): 1950-1959.
J Heart Cardiol | Volume 1: Issue 1www.ommegaonline.com